John W Kozarich
Director at Ligand Pharmaceuticals Inc (LGND)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 14SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 8042,173 held (−0%) | $227.37 | $18K | +32.7% |
| May 14SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 142,172 held (−0%) | $229.87 | $230 | +31.3% |
| May 14SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 16542,007 held (−0%) | $231.87 | $38K | +30.2% |
| May 14SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 10541,902 held (−0%) | $232.57 | $24K | +29.8% |
| May 14SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 11641,786 held (−0%) | $234.09 | $27K | +28.9% |
| May 14SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 45941,786 held (−1%) | $224.00 | $103K | +34.7% |
| May 14SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 1,57541,786 held (−4%) | $223.50 | $352K | +35.0% |
| Apr 2SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 14642,574 held (−0%) | $199.97 | $29K | +50.9% |
| Apr 2SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 4042,534 held (−0%) | $201.24 | $8K | +50.0% |
| Apr 2SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 7942,455 held (−0%) | $202.42 | $16K | +49.1% |
| Apr 2SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 4342,412 held (−0%) | $202.91 | $9K | +48.7% |
| Apr 2SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 15942,253 held (−0%) | $204.26 | $32K | +47.8% |
| Mar 4SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 4743,140 held (−0%) | $197.14 | $9K | +53.1% |
| Mar 4SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 20442,936 held (−0%) | $199.69 | $41K | +51.1% |
| Mar 4SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 4142,895 held (−0%) | $200.40 | $8K | +50.6% |
| Mar 4SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 8342,812 held (−0%) | $201.65 | $17K | +49.7% |
| Mar 4SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 5042,762 held (−0%) | $202.54 | $10K | +49.0% |
| Mar 4SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 4242,720 held (−0%) | $203.57 | $9K | +48.3% |
| Feb 4SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 3943,615 held (−0%) | $191.00 | $7K | +58.0% |
| Feb 4SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 143,614 held (−0%) | $192.18 | $192 | +57.0% |
| Feb 4SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 2343,591 held (−0%) | $195.61 | $4K | +54.3% |
| Feb 4SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 38143,210 held (−1%) | $196.36 | $75K | +53.7% |
| Feb 4SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 2343,187 held (−0%) | $197.20 | $5K | +53.0% |
| Jan 6SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 2144,100 held (−0%) | $186.59 | $4K | +61.8% |
| Jan 6SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 9144,009 held (−0%) | $187.95 | $17K | +60.6% |
| Jan 6SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 10243,907 held (−0%) | $188.96 | $19K | +59.7% |
| Jan 6SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 20743,700 held (−0%) | $190.27 | $39K | +58.6% |
| Jan 6SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 4643,654 held (−0%) | $192.40 | $9K | +56.9% |
| Dec 3SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 9244,496 held (−0%) | $193.86 | $18K | +55.7% |
| Dec 3SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 17944,317 held (−0%) | $194.76 | $35K | +55.0% |
| Dec 3SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 4744,270 held (−0%) | $195.80 | $9K | +54.1% |
| Dec 3SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 444,266 held (−0%) | $196.35 | $785 | +53.7% |
| Dec 3SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 9244,174 held (−0%) | $197.72 | $18K | +52.6% |
| Dec 3SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 2344,151 held (−0%) | $199.22 | $5K | +51.5% |
| Dec 3SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 3044,121 held (−0%) | $200.02 | $6K | +50.9% |
| Nov 5SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 8444,971 held (−0%) | $189.00 | $16K | +59.7% |
| Nov 5SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 4944,922 held (−0%) | $190.26 | $9K | +58.6% |
| Nov 5SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 20744,715 held (−0%) | $191.25 | $40K | +57.8% |
| Nov 5SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 12744,588 held (−0%) | $192.38 | $24K | +56.9% |
| Oct 3SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 2445,498 held (−0%) | $177.60 | $4K | +69.9% |
| Oct 3SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 19645,302 held (−0%) | $178.41 | $35K | +69.2% |
| Oct 3SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 15545,147 held (−0%) | $180.01 | $28K | +67.7% |
| Oct 3SEC | LGNDLigand Pharmaceuticals Inc | Sell Plan | 9245,055 held (−0%) | $181.18 | $17K | +66.6% |
- Sell
Director John W Kozarich sold $18K of LGND at $227.37 — pre-scheduled 10b5-1 plan sale.
- Sell
Director John W Kozarich sold $230 of LGND at $229.87 — pre-scheduled 10b5-1 plan sale.
- Sell
Director John W Kozarich sold $38K of LGND at $231.87 — pre-scheduled 10b5-1 plan sale.
- Sell
Director John W Kozarich sold $24K of LGND at $232.57 — pre-scheduled 10b5-1 plan sale.
- Sell
Director John W Kozarich sold $27K of LGND at $234.09 — pre-scheduled 10b5-1 plan sale.
- Sell
Director John W Kozarich sold $103K of LGND at $224.00 — pre-scheduled 10b5-1 plan sale.